E6-2726. Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Focus Groups as Used by the Food and Drug Administration  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice.

    SUMMARY:

    The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

    DATES:

    Fax written comments on the collection of information by March 29, 2006.

    ADDRESSES:

    OMB is still experiencing significant delays in the regular mail, including first class and express mail, and messenger deliveries are not being accepted. To ensure that comments on the information collection are received, OMB recommends that written comments be faxed to the Office of Information and Regulatory Affairs, OMB, Attn: Fumie Yokota, Desk Officer for FDA, FAX: 202-395-6974.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Jonna Capezzuto, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In compliance with 44 U.S.C. 3507, FDA has submitted the following proposed collection of information to OMB for review and clearance.

    Focus Groups as Used by the Food and Drug Administration—(OMB Control Number 0910-0497)—Extension

    FDA will collect and use information gathered through the focus group vehicle. This information will be used to develop programmatic proposals, and as such, compliments other important research findings to develop these proposals. Focus groups do provide an important role in gathering information because they allow for a more in-depth understanding of consumers' attitudes, beliefs, motivations, and feelings than do quantitative studies.

    Also, information from these focus groups will be used to develop policy and redirect resources, when necessary, to our constituents. If this information is not collected, a vital link in information gathering by FDA to develop policy and programmatic proposals will be missed causing further delays in policy and program development.

    In the Federal Register of November 25, 2005 (FR 70 71165), FDA published a 60-day notice requesting public comment on the information collection provisions. FDA received one comment, however it was not related to the information collection.

    Annually, FDA projects about 28 focus group studies using 286 focus groups lasting an average of 1.78 hours each. FDA has allowed burden for unplanned focus groups to be completed so as not to restrict the agency's ability to gather information on public sentiment for its proposals in its regulatory as well as other programs. To arrive at each center's estimated burden we multiplied the number of focus groups per study by the number of participants per group. (e.g., Center for Biologics Evaluation and Research (CBER): 5x9=45). We multiplied that total by the hours of duration for each group to arrive at the total burden hours. (e.g., CBER: 45x1.58=71.1).

    The total annual estimated burden imposed by this collection of information is 4,252 hours annually.

    FDA estimates the burden of this collection of information as follows:

    Table 1.—Estimated Annual Reporting Burden1

    FDA CenterSubjectNo. of Focus Groups per StudyNo. of Focus Groups Sessions Conducted AnnuallyNo. of Participants per GroupHours of Duration for Each Group (Includes Screening)Total Hours
    Center for Biologics Evaluation and ResearchMay use focus groups when appropriate1591.5871
    Center for Drug Evaluation and ResearchVaries (e.g., direct-to-consumer Rx drug promotion, physician labeling of Rx drugs, medication guides, over-the-counter drug labeling, risk communication)1020091.582,844
    Center for Devices and Radiological HealthVaries (e.g., FDA Seal of Approval, patient labeling, tampons, on-line sales of medical products, latex gloves)41692.08300
    Center for Food Safety and Applied NutritionVaries (e.g., food safety, nutrition, dietary supplements, and consumer education)84091.58569
    Center for Veterinary MedicineVaries (e.g., animal nutrition, supplements, labeling of animal Rx)52592.08468
    Start Printed Page 9829
    Total282861.784,252
    1 There are no capital costs or operating and maintenance costs associated with this collection of information.
    Start Signature

    Dated: February 21, 2006.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E6-2726 Filed 2-24-06; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Published:
02/27/2006
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
E6-2726
Dates:
Fax written comments on the collection of information by March 29, 2006.
Pages:
9828-9829 (2 pages)
Docket Numbers:
Docket No. 2005N-0443
PDF File:
e6-2726.pdf